Rock Springs Capital Management LP Q1 2018 Filing
Filed May 15, 2018
Portfolio Value
$2.3T
Holdings
148
Report Date
Q1 2018
Filing Type
13F-HR
All Holdings (148 positions)
| Stock | Value |
|---|---|
—LA JOLLA PHARMACEUTICAL CO | $6.6M |
CBAYUSDCYMABAY THERAPEUTICS INC | $6.4M |
ZLABZAI LAB LTD | $6.3M |
—GTX INC DEL | $6.3M |
—MYOVANT SCIENCES LTD | $6.3M |
—MOMENTA PHARMACEUTICALS INC | $6.3M |
—ENDOCYTE INC | $6.1M |
AG8AGILENT TECHNOLOGIES INC | $6.1M |
—PARATEK PHARMACEUTICALS INC | $5.8M |
MRTXEURMIRATI THERAPEUTICS INC | $5.8M |
NVAXNOVAVAX INC | $5.8M |
—THERAPEUTICSMD INC | $5.7M |
—SHIRE PLC | $5.6M |
INSM 1.75 01/15/25INSMED INC | $5.4M |
—CLEMENTIA PHARMACEUTICALS IN | $5.2M |
ADVMCHFADVERUM BIOTECHNOLOGIES INC | $5.2M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $5.2M |
—AIMMUNE THERAPEUTICS INC | $5.1M |
DVAXDYNAVAX TECHNOLOGIES CORP | $5.0M |
—MEDICINES CO | $4.8M |
—DERMIRA INC | $4.8M |
—ALDER BIOPHARMACEUTICALS INC | $4.6M |
BCRXBIOCRYST PHARMACEUTICALS | $4.4M |
ITCIEURINTRA CELLULAR THERAPIES INC | $3.9M |
EX9EXELIXIS INC | $3.9M |
CGENCOMPUGEN LTD | $3.7M |
—MEDICINES CO | $3.5M |
MRUSMERUS N V | $3.2M |
—PROTEOSTASIS THERAPEUTICS IN | $3.2M |
—RA PHARMACEUTICALS INC | $3.2M |
—EGALET CORP | $3.2M |
—NABRIVA THERAPEUTICS PLC | $3.1M |
—ALLERGAN PLC | $3.0M |
—CARDIOME PHARMA CORP | $2.8M |
—RESTORBIO INC | $2.6M |
—DBV TECHNOLOGIES S A | $1.7M |
MCRB1EURSERES THERAPEUTICS INC | $1.6M |
—THERAVANCE BIOPHARMA INC | $1.5M |
—RADIUS HEALTH INC | $1.5M |
RYTMRHYTHM PHARMACEUTICALS INC | $1.4M |
—CIDARA THERAPEUTICS INC | $1.2M |
SCYXEURSCYNEXIS INC | $1.1M |
—WRIGHT MED GROUP INC | $1.0M |
SLDBSOLID BIOSCIENCES INC | $938K |
—PACIRA PHARMACEUTICALS INC | $912K |
—CHIASMA INC | $788K |
INFIQINFINITY PHARMACEUTICALS INC | $567K |
KURAKURA ONCOLOGY INC | $497K |
PreviousPage 2 of 2